dc.contributor.author | Halpin, David M. G. | |
dc.contributor.author | Kerkhof, Marjan | |
dc.contributor.author | Soriano, Joan B. | |
dc.contributor.author | Mikkelsen, Helga | |
dc.contributor.author | Price, David B. | |
dc.date.accessioned | 2016-10-03T12:00:10Z | |
dc.date.available | 2016-10-03T12:00:10Z | |
dc.date.issued | 2016-09-23 | |
dc.identifier | 71318875 | |
dc.identifier | bc268e19-7c21-47f0-b893-53090d040d2b | |
dc.identifier | 27663386 | |
dc.identifier | 84988603222 | |
dc.identifier.citation | Halpin , D M G , Kerkhof , M , Soriano , J B , Mikkelsen , H & Price , D B 2016 , ' Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy ' , Respiratory Research , vol. 17 , 120 , pp. 1-13 . https://doi.org/10.1186/s12931-016-0433-5 | en |
dc.identifier.issn | 1465-9921 | |
dc.identifier.uri | http://hdl.handle.net/2164/7564 | |
dc.description | Acknowledgments The authors wish to acknowledge Derek Skinner with gratitude for his assistance with data extraction and analysis. Funding Data access and analyses were funded by Boehringer Ingelheim, who played no role in the conduct or reporting of the study | en |
dc.format.extent | 13 | |
dc.format.extent | 608831 | |
dc.language.iso | eng | |
dc.relation.ispartof | Respiratory Research | en |
dc.subject | randomised controlled trial | en |
dc.subject | real-life research | en |
dc.subject | chronic obstructive pulmonary disease | en |
dc.subject | long-acting bronchodilators | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1186/s12931-016-0433-5 | |